Purpose: To examine the effects of stage duration on power output (PO), oxygen uptake (VO), and heart rate (HR) at peak level and ventilatory thresholds during synchronous arm crank ergometry.

Methods: Nineteen healthy participants completed a ramp, 1-min stepwise, and 3-min stepwise graded arm crank exercise test. PO, VO and HR at the first and second ventilatory threshold (VT1, VT2) and peak level were compared among the protocols: a repeated measures analysis of variance was performed to test for systematic differences, while intraclass correlation coefficients (ICC) and Bland-Altman plots were calculated to determine relative and absolute agreement.

Results: Systematic differences among the protocols were found for PO at VT1, VT2, and peak level. At peak level, PO differed significantly among all protocols (ramp: 115 ± 37 W; 1-min stepwise: 108 ± 34 W; 3-min stepwise: 94 ± 31 W, p ≤ 0.01). No systematic differences for HR or VO were found among the protocols. VT1 and VT2 were identified at 52% and 74% of VOpeak, respectively. The relative agreement among protocols varied (ICC 0.02-0.97), while absolute agreement was low with small-to-large systematic error and large random error.

Conclusions: PO at VTs and peak level was significantly higher in short-stage protocols compared with the 3-min stepwise protocol, whereas HR and VO showed no differences. Therefore, training zones based on PO determined in short-stage protocols might give an overestimation. Moreover, due to large random error in HR at VTs between the protocols, it is recommended that different protocols should not be used interchangeably within individuals.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763408PMC
http://dx.doi.org/10.1007/s00421-019-04211-9DOI Listing

Publication Analysis

Top Keywords

peak level
20
arm crank
12
3-min stepwise
12
vt1 vt2
12
systematic differences
12
protocols
9
ventilatory thresholds
8
synchronous arm
8
1-min stepwise
8
vt2 peak
8

Similar Publications

Anticoagulation of HeartMate 3 Left Ventricular Assist Device With Apixaban.

Ann Thorac Surg Short Rep

March 2024

Division of Cardiac Surgery, Alberta Health Services, Edmonton, Alberta, Canada.

We report a case of a 56-year-old man requiring a HeartMate 3 after a myocardial infarction and limited recovery on a temporary ventricular assist device. Because of several gastrointestinal bleeding complications and nonadherence, his antithrombotic therapy was switched from warfarin and aspirin to apixaban 5 mg twice daily. We also determined several peak anti-factor Xa levels for ongoing monitoring.

View Article and Find Full Text PDF

Background: Acute myocardial infarction complicated by cardiogenic shock (AMICS) is frequently preceded by out-of-hospital cardiac arrest (OHCA), with risk of anoxic brain injury. Neuron-specific enolase (NSE) is central to neuroprognostication; however, concomitant hemolysis can increase NSE independent of neuronal injury due to the presence of NSE in erythrocytes. This consideration is critical in AMICS patients treated with a microaxial flow pump (Impella, Abiomed), where hemolysis is frequent.

View Article and Find Full Text PDF

Introduction: COVID-19 has caused tremendous hardships and challenges around the globe. Due to the prevalence of asymptomatic and pre-symptomatic carriers, relying solely on disease testing to screen for infections is not entirely reliable, which may affect the accuracy of predictions about the pandemic trends. This study is dedicated to developing a predictive model aimed at estimating of the dynamics of COVID-19 at an early stage based on wastewater data, to assist in establishing an effective early warning system for disease control.

View Article and Find Full Text PDF

Background: Older adults with cancer are vulnerable to declines in muscle performance (e.g., strength, speed, duration of muscular contraction), which are associated with worse cancer-related outcomes.

View Article and Find Full Text PDF

Activation of the De Novo Serine Synthesis Pathway and Disruption of Insulin Signaling Induced by Supplemental SeMet in Vitro.

Biol Trace Elem Res

January 2025

Department of Nutrition and Metabolism, Chinese Center for Disease Control and Prevention, National Institute for Nutrition and Health, Beijing, 100050, China.

Selenium (Se) intake or selenoprotein overexpression can cause abnormal glucose metabolism and increase the risk of type 2 diabetes (T2D). The purpose of this study is to observe whether glycolysis bypass in the de novo serine synthesis pathway (SSP) is activated under high-Se stress in vitro. Initially, HCT-116, L02, HepG2, and differentiated C2C12 cells were exposed to five selenomethionine (SeMet) concentrations (0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!